Accrued Liabilities and Other Liabilities

3 Months Ended

Mar. 31, 2022

Payables and Accruals [Abstract]

Accrued Liabilities and Other Liabilities

Accrued Liabilities and Other Liabilities

Accrued liabilities consisted of the following (in thousands):

	March 31,		December 31,
	2022		2021
Accrued clinical expense	$	30,411	$	29,038
Accrued manufacturing expense	33,318		34,153
Accrued development expense	7,282		10,910
Accrued compensation and benefits	15,559		25,845
Other accrued expenses	9,063		8,549
	$	95,633	$	108,495

The long-term liabilities balance of $2.6 million as of March 31, 2022, and $2.2 million as of December 31, 2021, consisted primarily of clinical trial-related liabilities.